DRAP Issues Alert Over Fake Vaccine for Children

For context, the Drug Regulatory Authority of Pakistan (DRAP) has issued an alert over a falsified version of the Hexaxim vaccine.

HealthNews Info Wire2 min read
Pakistan Faces Shortage of Flu Vaccines

For context, the Drug Regulatory Authority of Pakistan (DRAP) has issued an alert over a falsified version of the Hexaxim vaccine.

Article outline

  1. What happened
  2. Why it matters
  3. The bottom line

Key points

  • According to DRAP, Hoechst Pakistan Limited, the local distributor of Sanofi, documented that Hexaxim vaccine bearing batch number X3H421VA was being presented in vial form.
  • After the alert, the authority directed its Regulatory Field Force and provincial drug control departments to monitor the supply chain and confiscate the identified product wherever identified.
  • The firm clarified that Hexaxim is registered in Pakistan only in pre-filled syringe form.
  • The vaccine protects children against six diseases, including diphtheria, tetanus, whooping cough, hepatitis B, polio, and infections caused by Haemophilus influenzae type b (Hib).
  • Parents and healthcare providers have been advised not to purchase or employ the affected vaccine.

According to DRAP, Hoechst Pakistan Limited, the local distributor of Sanofi, documented that Hexaxim vaccine bearing batch number X3H421VA was being presented in vial form. It is neither registered nor authorized for import into Pakistan. CDA Gives Islamabad Major Markets a Facelift.

For context, the firm clarified that Hexaxim is registered in Pakistan only in pre-filled syringe form.

Notably, the vaccine protects children against six diseases, including diphtheria, tetanus, whooping cough, hepatitis B, polio, and infections caused by Haemophilus influenzae type b (Hib).

DRAP cautioned that using the falsified vaccine could pose serious health risks, including failure to provide the intended protection and adverse reactions.

After the alert, the authority directed its Regulatory Field Force and provincial drug control departments to monitor the supply chain and confiscate the identified product wherever identified. NCCIA Urges Responsible Digital Journalism and Social Media Employ.

Parents and healthcare providers have been advised not to purchase or employ the affected vaccine. Anyone who has received it and experienced health challenges should immediately consult a doctor and report the incident to DRAP or the National Pharmacovigilance Centre.

DRAP additionally called on the public to purchase vaccines and medicines only from licensed pharmacies and authorized outlets and to consult healthcare professionals if they have reservations concerning a product's authenticity. Stay Connected with ProPakistani. Obtain the latest news and stories wherever you prefer. Follow on Google Discover. Follow on Google News Join WhatsApp. See more ProPakistani stories in Google Search and Top Stories.

For now, DRAP Issues Alert Over Fake Vaccine for Children remains the part of the story worth watching, and further updates are likely as more details are confirmed.

Leave a Reply

Your email address will not be published. Required fields are marked *